Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00722267
NCT00722267
Completed
Not Applicable

Patient Perception of Symptom Variability. A Cross-sectional Study of Patients With Severe COPD.

AstraZeneca1 site in 1 country7,400 target enrollmentJuly 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Obstructive Pulmonary Disease (COPD)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Sponsor
AstraZeneca
Enrollment
7400
Locations
1
Primary Endpoint
Patient's perception of the variability of symptoms due to severe stable state COPD throughout the day, the week and the year
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study is investigating how patients with severe stable state COPD perceive the variability of their symptoms throughout the day, the week and the year; the impact of these variations on their daily activities or sleep quality and how they deal with their treatments. For this purpose patients will be asked to answer a questionnaire over the phone

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
February 2009
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Outpatients with a diagnosis of COPD
  • •FEV1\<50% and FEV1/FVC\<0.7 according to lung function data in medical records.
  • •Smoker or ex-smoker \> 10 pack-years
  • •Informed consent obtained

Exclusion Criteria

  • •Ongoing exacerbation of COPD or within the previous 3 months
  • •Any other significant respiratory disease (including asthma and allergic rhinitis)

Outcomes

Primary Outcomes

Patient's perception of the variability of symptoms due to severe stable state COPD throughout the day, the week and the year

Time Frame: Once

Secondary Outcomes

  • Factors that may influence the patient's perception of symptom variability(Once)
  • Describe how patient use their COPD treatment(Once)
  • Impact of symptoms (and variability of symptoms) on the patient's morning & daily living activities and sleep quality.(Once)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Perception of Symptom Variability in COPDChronic Obstructive Pulmonary Disease
NCT01753427AstraZeneca1,058
Completed
Not Applicable
A Cross-sectional Study of COPD and Symptom Variability in MEA CountriesChronic Obstructive Pulmonary Disease
NCT03425760AstraZeneca3,254
Completed
Not Applicable
Evaluation of a symptom-based COPD population screener (COPD-PS) questionnaire for screening of COPD in primary carechronic disease
JPRN-UMIN000011433Ishinomaki COPD Network1,000
Completed
Not Applicable
Dyspnea in COPD: Relationship With Exacerbations FrequencyDyspnea
NCT02113839Hospital Clinic of Barcelona34
Completed
Not Applicable
Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive (COPD)
NCT02551224Novartis Pharmaceuticals100